Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 3/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 3/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30972746 | 1.00 | TRPA1 (0.44) | TRPA1ATMKDM4EALDH1A1GAA | |
| SCHEMBL25077559 | 0.83 | ESR2 (0.44) | TRPA1ATMKDM4EALDH1A1GAA | |
| SCHEMBL4930118 | 0.81 | TP53 (0.40) | TRPA1ATMKDM4EALDH1A1GAA | |
| SCHEMBL5951211 | 0.79 | TRPA1 (0.44) | TRPA1ATMKDM4EALDH1A1GAA | |
| SCHEMBL6062069 | 0.79 | ALDH1A1 (0.41) | TRPA1ATMKDM4EALDH1A1GAA | |
| SCHEMBL31065736 | 0.79 | TRPA1 (0.44) | TRPA1ATMKDM4EALDH1A1GAA | |
| SCHEMBL10753626 | 0.77 | NCEH1 (0.42) | TRPA1ATMALDH1A1NCEH1POLB | |
| SCHEMBL16334112 | 0.75 | TP53 (0.36) | TRPA1KDM4EALDH1A1GAAHTT | |
| SCHEMBL15476296 | 0.75 | CYP3A4 (0.42) | TRPA1KDM4EALDH1A1GAAHTT | |
| SCHEMBL7524173 | 0.75 | KDM4E (0.39) | TRPA1ATMKDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140135297-A1 | AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2014-05-15 | — | — | US | claimed |
| CN-1953658-A | Antimicrobial silicon oxide flakes | CIBA SC HOLDING AG (CH) | 2007-04-25 | — | — | CN | claimed |
| EP-4638438-A1 | ALPHA4 BETA7 INTEGRIN ANTAGONISTS AND USES THEREOF | Xinthera, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| CN-120202209-A | Modified cholic acid conjugate | 乌尔特拉有限责任公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-119562805-A | Cannabinoid lipid premix | 费尔廷制药公司 | 2025-03-04 | — | — | CN | disclosed |
| EP-3653303-B1 | PIPETTE TIP RACK | BIOTIX INC (US) | 2025-02-26 | — | — | EP | disclosed |
| US-12201987-B2 | Pipette tip rack | BIOTIX, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-20240279214-A1 | ALPHA4 BETA7 INEGRIN ANTAGONISTS AND USES THEREOF | XINTHERA, INC. | 2024-08-22 | — | — | US | disclosed |
| CN-112153964-B | Oral tablets suitable for active pharmaceutical ingredient comprising non-directly compressible sugar alcohol particles | 费尔廷制药公司 | 2024-07-30 | — | — | CN | disclosed |
| WO-2024138042-A1 | ALPHA4 BETA7 INTEGRIN ANTAGONISTS AND USES THEREOF | XINTHERA, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024138042-A1 | ALPHA4 BETA7 INTEGRIN ANTAGONISTS AND USES THEREOF | XINTHERA, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| US-20110183433-A1 | PIPETTE TIPS | BIOTIX, INC. (US) | 2011-07-28 | — | — | US | disclosed |
| WO-2011091308-A2 | PIPETTE TIPS | BIOTIX, INC. (US) | 2011-07-28 | — | — | WO | disclosed |
| CN-101802316-A | Improvements in lavatory treatment devices | RECKITT BENCKISER INC | 2010-08-11 | — | — | CN | disclosed |
| WO-2010008737-A2 | ANTIMICROBIAL FLUID HANDLING DEVICES AND METHODS OF MANUFACTURE | PELICAN GROUP HOLDINGS, INC. (US) | 2010-01-21 | — | — | WO | disclosed |
| US-7638470-B2 | Cleaning | RECKITT BENCKISER (UK) LIMITED (GB) | 2009-12-29 | — | — | US | disclosed |
| EP-1879457-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | Ciba Specialty Chemicals Holding, Inc. (CH) | 2008-01-23 | — | — | EP | disclosed |
| CN-1953658-A | Antimicrobial silicon oxide flakes | CIBA SC HOLDING AG (CH) | 2007-04-25 | — | — | CN | disclosed |
| WO-2006120135-A1 | ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-11-16 | — | — | WO | disclosed |
| CN-1331739-A | Fabric color care method | PROCTER & GAMBLE (US) | 2002-01-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279214-A1 | ALPHA4 BETA7 INEGRIN ANTAGONISTS AND USES THEREOF | ITGB7, ITGB4, ITGA4 | TRPA1 2715/4885ATM 4276/4885KDM4E 3588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.